Nobuhisa Hagiwara    Department   Other, Other    Position
Article types	Original article
Language	English
Peer review	Peer reviewed
Title	Identification of MYLK3 mutations in familial dilated cardiomyopathy.
Journal	Formal name：Scientific reports Abbreviation：Sci Rep ISSN code：2045-2322
Domestic / Foregin	Foregin
Publisher	Nature Research
Volume, Issue, Page	7(1),pp.17495
Author and coauthor	Tobita Takashige†, Nomura Seitaro, Morita Hiroyuki, Ko Toshiyuki, Fujita Takanori, Toko Haruhiro, Uto Kenta, Hagiwara Nobuhisa, Aburatani Hiroyuki*, Komuro Issei*
Publication date	2017/12
Summary	Dilated cardiomyopathy (DCM) is a primary cause of heart failure, life-threatening arrhythmias, and cardiac death. Pathogenic mutations have been identified at the loci of more than 50 genes in approximately 50% of DCM cases, while the etiologies of the remainder have yet to be determined. In this study, we applied whole exome sequencing in combination with segregation analysis to one pedigree with familial DCM, and identified a read-through mutation (c.2459 A > C; p.*820Sext*19) in the myosin light chain kinase 3 gene (MYLK3). We then conducted MYLK3 gene screening of 15 DCM patients (7 familial and 8 sporadic) who were negative for mutation screening of the previously-reported cardiomyopathy-causing genes, and identified another case with a MYLK3 frameshift mutation (c.1879_1885del; p.L627fs*41). In vitro experiments and immunohistochemistry suggested that the MYLK3 mutations identified in this study result in markedly reduced levels of protein expression and myosin light chain 2 phosphorylation. This is the first report that MYLK3 mutations can cause DCM in humans. The clinical phenotypes of DCM patients were consistent with MYLK3 loss-of-function mouse and zebrafish models in which cardiac enlargement and heart failure are observed. Our findings highlight an essential role for cardiac myosin light chain kinase in the human heart.
DOI	10.1038/s41598-017-17769-1
PMID	29235529